SCHEMBL8178159

SCHEMBL8178159

CC(C)(NN)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.46
KCNN4 O15554 4/20 0.44
MAPK1 P28482 1/20 0.44
MAPT P10636 1/20 0.43
KMT2A Q03164 1/20 0.43
ALDH1A1 P00352 2/20 0.41
ALOX15 P16050 1/20 0.41
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40
ESR1 P03372 2/20 0.39
ESR2 Q92731 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL31564741 0.97 TAAR1 (0.44) TAAR1KCNN4MAPK1MAPTKMT2A
Biphenyl SCHEMBL27616143 0.93 TAAR1 (0.41) TAAR1KCNN4MAPK1MAPTKMT2A
SCHEMBL28484440 0.79 TAAR1 (0.46) TAAR1KCNN4MAPK1MAPTKMT2A
SCHEMBL471139 0.78 KCNN4 (0.48) TAAR1KCNN4MAPK1MAPTKMT2A
SCHEMBL8029072 0.77 TSHR (0.52) MAPTKMT2AALDH1A1HDAC1HDAC6
SCHEMBL663244 0.76 KCNN4 (0.59) TAAR1KCNN4MAPK1MAPTKMT2A
SCHEMBL18539275 0.75 KIF11 (0.41) MAPK1MAPTKMT2AALDH1A1CYP3A4
SCHEMBL10535334 0.75 ESR1 (0.54) MAPTKMT2AALDH1A1ALOX15ESR1
SCHEMBL15275693 0.75 TAAR1 (0.43) TAAR1KCNN4MAPK1MAPTKMT2A
SCHEMBL7570225 0.74 KCNN4 (0.44) TAAR1KCNN4MAPK1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115397809-A Macrocyclic pantetheine derivatives and uses thereof 彗星医疗股份有限公司 2022-11-25 CN disclosed
CN-110563701-B N-2-pyrimidine-2-azido-3- (2,2,6, 6-tetramethylpiperidinyloxy) indoline and preparation and application thereof 浙江工业大学 2022-09-16 CN disclosed
CN-114929659-A Co-crystals of pterostilbene and compositions comprising them 晶体工程智能研究中心公司 2022-08-19 CN disclosed
CN-114846019-A Co-crystals of steroids and secosteroids and compositions containing same 晶体工程智能研究中心公司 2022-08-02 CN disclosed
CN-112574180-B N-2-pyrimidinyl-3-fluoroindole compound and preparation method and application thereof 浙江工业大学 2021-10-15 CN disclosed
US-20210300935-A1 PYRAZOLO-QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS Nerviano Medical Sciences, S.R.L. (IT) 2021-09-30 US disclosed
CN-112574180-A N-2-pyrimidinyl-3-fluoroindole compound and preparation method and application thereof 浙江工业大学 2021-03-30 CN disclosed
CN-110511208-B N-2-pyridyl-2, 3-diazido indoline compound and preparation and application thereof 浙江工业大学 2020-08-25 CN disclosed
CN-111095102-A Photosensitive resin composition, dry film and printed wiring board 互应化学工业株式会社 2020-05-01 CN disclosed
CN-110563701-A N-2-pyrimidine-2-azido-3- (2,2,6, 6-tetramethylpiperidinyloxy) indoline and preparation and application thereof 浙江工业大学 2019-12-13 CN disclosed
US-4919916-A Treatment of neurotransmitter-linked drug abuse GOLWYN DANIEL H (US) 1990-04-24 US disclosed
EP-0347216-A2 Insecticidal N'-substituted-N-alkylcarbonyl-N'-acylhydrazines and N'-substituted -N-acyl-N'-alkylcarbonyl hydrazines ROHM AND HAAS COMPANY (US) 1989-12-20 EP disclosed
US-4786653-A Treatment of neurotransmitter-linked drug abuse GOLWYN DANIEL H (US) 1988-11-22 US disclosed
EP-0286746-A1 Insecticidal N-(optionally substituted) - N'-substituted-N,N'-disubstituted- hydrazines ROHM AND HAAS COMPANY (US) 1988-10-19 EP disclosed
EP-0261755-A2 Five-membered heterocyclic derivatives of N'-substituted-N,N'-Diacylhydrazines ROHM AND HAAS COMPANY (US) 1988-03-30 EP disclosed
EP-0253468-A2 Six-membered heterocyclic derivatives of N'substituted-N,N'-diacylhydrazines ROHM AND HAAS COMPANY (US) 1988-01-20 EP disclosed
EP-0245950-A2 Insecticidal n-substituted-n' - substituted-n, n'-diacylhydrazines ROHM AND HAAS COMPANY (US) 1987-11-19 EP disclosed
EP-0236618-A2 Insecticidal N'-substituted-N,N'-diacylhydrazines ROHM AND HAAS COMPANY (US) 1987-09-16 EP disclosed
EP-0234944-A1 Insecticidal N'-substituted-N-acyl-N'-alkylcarbonylhydrazines ROHM AND HAAS COMPANY (US) 1987-09-02 EP disclosed
EP-0232075-A1 Insecticidal N'-substituted-N-alkylcarbonyl-N'-acyl hydrazines ROHM AND HAAS COMPANY (US) 1987-08-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210300935-A1 PYRAZOLO-QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS MAP3K5, MAP3K9, MAP4K2 TAAR1 4513/4885KCNN4 2752/4885MAPK1 73/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.